A $10bn (£7.4bn) takeover of Walgreens Boots Alliance (WBA) by Sycamore Partners has been officially approved, with 96% of ...

Shareholders of Walgreens Boots Alliance overwhelmingly approved the drugstore chain’s $10 billion acquisition by private ...

Walgreens Boots Alliance should be a private company before the end of the year after jumping the potential hurdle of a ...

The transaction, expected to close in Q3 or Q4, will take the company private after nearly 100 years as a public company.

Walgreens Boots Alliance (WBA) said on Friday that the struggling drug retailer’s shareholders approved its $10 billion ...

The deal, announced on March 6, would allow Sycamore Partners to take Walgreens private. The drug-store chain expects the transaction to close in the third or fourth quarter of 2025.

Shareholders for Walgreens Boots Alliance overwhelmingly voted to approve the company’s sale to Sycamore Partners, with 96% of shareholders at a special meeting voting to green-light the merger, ...

Retail Gazette takes a closer look at Boots' new private equity owner and what the deal means for the future of the health ...

Walgreens' $10B sale to Sycamore Partners ends a long decline for one of Chicago’s most iconic companies — and raises ...

Walgreens in March agreed to be taken private by PE firm Sycamore Partners for $10 billion, closing out nearly a century of trading on public markets for the U.S. pharmacy giant.

The term "special situations" covers a lot of ground on Wall Street. In the case of Walgreens, the situation that is special is that the company is being taken private. Essentially, it is being bought ...

The drugstore industry is facing competition from the likes of Amazon.com Inc., as well as pressure on pharmacy-reimbursement rates for prescription drugs.